(NASDAQ: #MMSI)
#MeritMedical announced a $22M deal to acquire the C2 CryoBalloon technology from Pentax of America, expanding its endoscopy portfolio. The minimally invasive GI device targets Barrett’s esophagus and GERD.
prismmarketview.com/merit-medica...
#MeritMedical announced a $22M deal to acquire the C2 CryoBalloon technology from Pentax of America, expanding its endoscopy portfolio. The minimally invasive GI device targets Barrett’s esophagus and GERD.
prismmarketview.com/merit-medica...
October 16, 2025 at 1:27 PM
Everybody can reply